Therapeutic role of resveratrol against hepatocellular carcinoma: A review on its molecular mechanisms of action
Open Access
- 1 March 2023
- journal article
- review article
- Published by Elsevier BV in Pharmacological Research - Modern Chinese Medicine
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- The Antimetastatic Effects of Resveratrol on Hepatocellular Carcinoma through the Downregulation of a Metastasis-Associated Protease by SP-1 ModulationPLOS ONE, 2013
- Resveratrol Down-Regulates Myosin Light Chain Kinase, Induces Apoptosis and Inhibits Diethylnitrosamine-Induced Liver Tumorigenesis in RatsInternational Journal of Molecular Sciences, 2013
- Resveratrol Regulates Antioxidant Status, Inhibits Cytokine Expression and Restricts Apoptosis in Carbon Tetrachloride Induced Rat Hepatic InjuryOxidative Medicine and Cellular Longevity, 2011
- Tumor Angiogenesis as a Target for Dietary Cancer PreventionJournal of Oncology, 2011
- Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cellsExperimental and Toxicologic Pathology, 2011
- Oxidative stress, inflammation, and cancer: How are they linked?Free Radical Biology & Medicine, 2010
- The p53 tumor suppressor: A master regulator of diverse cellular processes and therapeutic target in cancerBiochemical and Biophysical Research Communications, 2010
- Cellular signaling perturbation by natural productsCellular Signalling, 2009
- Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: Inhibition of cell proliferation and induction of apoptosisChemico-Biological Interactions, 2009
- Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated Kinase-1BMC Immunology, 2009